Genprex CEO Rodney Varner dies; CFO Ryan Confer appointed CEO and Board member

Genprex, Inc.

CEO/President/Chairman Rodney Varner passed away unexpectedly on May 7, 2024 due to illness complications.
Ryan Confer, CFO since 2016, appointed President and CEO effective May 8, 2024; also named to Board as Class III director.
Confer will continue as CFO until a permanent CFO is identified; Board has started a search.
Compensation Committee plans to review Confer's compensation in light of new responsibilities.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ryan Confer

President and Chief Executive Officer

GNPX · Genprex, Inc.

Effective: 2024-05-08
Filed: May 9, 2024, 7:59 PM ET

the Board appointed Ryan Confer, Chief Financial Officer of Genprex since 2016, to serve as President and Chief Executive Officer of Genprex (in addition to his position as Chief Financial Officer of Genprex), effective immediately

Appointed

Ryan Confer

Class III director

GNPX · Genprex, Inc.

Effective: 2024-05-08
Filed: May 9, 2024, 7:59 PM ET

On May 8, 2024, Mr. Confer was also appointed to the Board as a Class III director to fill the vacancy caused by Mr. Varner’s passing

Departed

Rodney Varner

President and Chief Executive Officer and Chairman

GNPX · Genprex, Inc.

Effective: 2024-05-07
Successor: Ryan Confer
Filed: May 9, 2024, 7:59 PM ET

Rodney Varner, the Company’s President and Chief Executive Officer and Chairman of the Company’s Board of Directors (the “Board”), passed away unexpectedly on May 7, 2024 due to complications from an ongoing illness.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Confer was appointed as President and Chief Executive Officer at Genprex, Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Board appointed Ryan Confer, Chief Financial Officer of Genprex since 2016, to serve as President and Chief Executive Officer of Genprex (in addition to his position as Chief Financial Officer of Genprex), effective immediately

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Confer was appointed as Class III director at Genprex, Inc..

Action: appointed
Role: Class III director

Exact text from the filing

On May 8, 2024, Mr. Confer was also appointed to the Board as a Class III director to fill the vacancy caused by Mr. Varner’s passing

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rodney Varner departed as President and Chief Executive Officer and Chairman at Genprex, Inc..

Action: passed away
Role: President and Chief Executive Officer and Chairman

Exact text from the filing

Rodney Varner, the Company’s President and Chief Executive Officer and Chairman of the Company’s Board of Directors (the “Board”), passed away unexpectedly on May 7, 2024 due to complications from an ongoing illness.

View on SEC.gov

Genprex, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-015471

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.